U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 021455

Expand all

BONIVA (IBANDRONATE SODIUM)
EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: IBANDRONATE SODIUM
Proprietary Name: BONIVA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N021455
Product Number: 001
Approval Date: May 16, 2003
Applicant Holder Full Name: HOFFMANN LA ROCHE INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
BONIVA (IBANDRONATE SODIUM)
EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: IBANDRONATE SODIUM
Proprietary Name: BONIVA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N021455
Product Number: 002
Approval Date: Mar 24, 2005
Applicant Holder Full Name: HOFFMANN LA ROCHE INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top